194934-72-0

Basic information

• Product Name: (S)-3-(allylamino)-2-(tert-butoxycarbonylamino)propanoic acid
• Synonyms: (S)-3-(allylamino)-2-(tert-butoxycarbonylamino)propanoic acid
• CAS NO: 194934-72-0
• Molecular Formula: C₁₁H₂₀N₂O₄
• Molecular Weight: 244.2875
• Mol File: 194934-72-0.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (S)-3-(allylamino)-2-(tert-butoxycarbonylamino)propanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-3-(allylamino)-2-(tert-butoxycarbonylamino)propanoic acid(194934-72-0)
• EPA Substance Registry System: (S)-3-(allylamino)-2-(tert-butoxycarbonylamino)propanoic acid(194934-72-0)

Safety Data

• Hazardous Substances Data: 194934-72-0(Hazardous Substances Data)

Upstream product

• 98541-64-1 (S)-3-(tert-butoxycarbonylamino)-oxetan-2-one 
• 107-11-9 1-amino-2-propene 
• 3262-72-4 (S)-N-(tert-butoxycarbonyl)serine 

Downstream Products

• 194934-75-3 (S)-N₂-(tert-butoxycarbonyl)-N₃-(benzyloxycarbonyl)-N₃-(2-propenyl)-2,3-diaminopropanoic acid 
• 138812-69-8 (S)-4-(benzyloxycarbonyl)piperazine-2-carboxylic acid 
• 194934-76-4 (S)-6-Hydroxy-piperazine-1,2,4-tricarboxylic acid 4-benzyl ester 1-tert-butyl ester 
• 138775-03-8 (S)-4-(benzyloxycarbonyl)-1-(tert-butyloxycarbonyl)-piperazine-2-carboxylic acid 

Relevant articles and documents

ISOBARIC MASS LABELS

The present invention relates to a set of two or more mass labels, wherein each mass label comprises the formula: [in-line-formulae]X-L-M-Re[/in-line-formulae] wherein X is a reporter moiety having an exact mass, L is a bond cleavable by collision in a ma

3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase

The present invention relates to certain novel 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase. Pharmaceutical compositions containing said compounds as well as methods of treating various disease states responding to inhibition of matrix metalloproteinase are also claimed herein.